Models in the development of clinical practice guidelines

Area of Science:

• Health policy
• Clinical decision-making
• Biostatistics

Background:

• Clinical practice guidelines rely on systematic reviews for evidence.
• Systematic reviews often lack data for benefit-harm tradeoff evaluations.
• Guideline development requires comprehensive evidence beyond primary research.

Purpose of the Study:

• To identify how modeling can address evidence gaps in guideline development.
• To explore the utility of modeling in evaluating interventions and outcomes.
• To demonstrate the application of modeling using cancer screening examples.

Main Methods:

• Identifying four key areas where modeling bridges evidence gaps.
• Applying modeling to disease risk, diagnostic tests, and treatment efficacy.
• Utilizing colorectal and breast cancer screening as case studies.

Main Results:

• Models can incorporate updated information on disease risk and treatment.
• Modeling allows exploration of diverse intervention strategies and long-term impacts.
• Modeling is most valuable when primary evidence is strong but gaps persist.

Conclusions:

• High-quality, validated models can supplement systematic reviews in guideline development.
• Modeling provides crucial data for evaluating benefits and harms over a lifetime.
• Model results inform healthcare practice and policy, especially for complex decisions.